GARM II: A Study on the Genetics of Age-related Maculopathy
Description: Dr. Michael Gorin at Jules Stein Eye Institute at UCLA is conducting a nationwide study of genetic and other risk factors that contribute to the development of age-related macular degeneration (also known as Age-Related Maculopathy). Affected individuals and family members may be eligible to participate in this observational study (this is not a treatment trial), which does not require travel to UCLA. Study participants will complete questionnaires through aconfidential and secure website.
Trial Status: Recruiting participants
Partial List of Eligibility Criteria:
- Individuals from 49 to 65 years old who have/had at least one parent with macular degeneration. Spouses or partners from 49 to 65 years old can also be included in the study.
- Age-Related Macular degeneration affected individuals with adult children ranging in age from 49 to 65 years old who are willing to participate in the study.
Clinical Trial Contact:
For more information, please call or email the GARM Study center at: 1-800-286-8581 or email@example.com
You can go to the GARM II website and read about the study with complete anonymity. www.jsei.org/garm
GARM II listing on ClinicalTrials.gov